Fig. 2From: Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerKaplan Meier curve showing the overall survival between patients on trastuzumab and patients who had interruption (unadjusted log-rank results)Back to article page